Results 211 to 220 of about 39,319 (333)
Combination Treatment of the Bruton's Tyrosine Kinase Inhibitor Ibrutinib and Carfilzomib in Patients with Relapsed or Relapsed and Refractory Multiple Myeloma: Initial Results from a Multicenter Phase 1/2b Study
, 2015 Ajai Chari, Saurabh Chhabra, Saad Z. Usmani, Sarah Larson, Rubén Niesvizky, Jeffrey Matous, Cristina Gasparetto, Beata Holkova, Matthew A. Lunning, Jason Valent, Larry D. Anderson, Chatchada Karanes, Long Kwei, L. Chang, Thorsten Graef, Elizabeth Bilotti, Kevin T. McDonagh +16 moreopenalex +1 more sourcePanobinostat acts synergistically with ibrutinib in diffuse large B cell lymphoma cells with MyD88 L265 mutations [PDF]
, 2017 Patrizia Mondello, Elliott J. Brea, Elisa de Stanchina, Eneda Toska, Aaron Y. Chang, Myles Fennell, Venkatraman Seshan, Ralph Garippa, David A. Scheinberg, José Baselga, Hans‐Guido Wendel, Anas Younes +11 moreopenalex +1 more sourceNear-tetraploidy is associated with Richter transformation in chronic lymphocytic leukemia patients receiving ibrutinib [PDF]
, 2017 Cecelia Miller, Amy S. Ruppert, Nyla A. Heerema, Kami J. Maddocks, Jadwiga Labanowska, H Breidenbach, Gerard Lozanski, Weiqiang Zhao, Amber Gordon, Jeffrey A. Jones, Joseph M. Flynn, Samantha Jaglowski, Leslie A. Andritsos, Kristie A. Blum, Farrukh T. Awan, Kerry A. Rogers, Michael R. Grever, Amy J. Johnson, Lynne V. Abruzzo, Erin Hertlein, James S. Blachly, Jennifer A. Woyach, John C. Byrd +22 moreopenalex +1 more sourceThe Addition of the BTK Inhibitor Ibrutinib to Anti-CD19 Chimeric Antigen Receptor T Cells (CART19) Improves Responses against Mantle Cell Lymphoma
, 2016 Marco Ruella, Saad S. Kenderian, Olga Shestova, Joseph A. Fraietta, Sohail Qayyum, Qian Zhang, Marcela V. Maus, Xiaobin Liu, Selene Nuñez-Cruz, Michael Klichinsky, Omkar U. Kawalekar, Michael C. Milone, Simon F. Lacey, Anthony R. Mato, Stephen J. Schuster, Michael Kalos, Carl H. June, Saar Gill, Mariusz A. Wasik +18 moreopenalex +1 more sourceINTEGRATED ANALYSIS: OUTCOMES OF IBRUTINIB‐TREATED PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LEUKEMIA (CLL/SLL) WITH HIGH‐RISK PROGNOSTIC FACTORS [PDF]
, 2017 Thomas J. Kipps, Graeme Fraser, Steven Coutré, Jennifer R. Brown, Jacqueline C. Barrientos, Paul M. Barr, John C. Byrd, Susan O’Brien, M.S. Dilhuydy, Peter Hillmen, Ulrich Jaeger, Carol Moreno, Paula Cramer, Stephan Stilgenbauer, A.A. Chanan‐Khan, Michelle Mahler, Mariya Salman, Minghua Cheng, Anil Londhe, Joi Ninomoto, Angela Howes, Danelle F. James, Michael Hallek +22 moreopenalex +1 more source